Original Research
Published on 07 Mar 2017
The Smac Mimetic BV6 Improves NK Cell-Mediated Killing of Rhabdomyosarcoma Cells by Simultaneously Targeting Tumor and Effector Cells
in Alloimmunity and Transplantation
Frontiers in Immunology
doi 10.3389/fimmu.2017.00202
- 6,815 views
- 23 citations
